NCT05306301 2026-03-06Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia PatientsGruppo Italiano Malattie EMatologiche dell'AdultoPhase 2 Active not recruiting32 enrolled
NCT05268003 2026-03-05A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic LeukemiaM.D. Anderson Cancer CenterPhase 2 Active not recruiting26 enrolled